CT scans may predict breast reconstruction flap failure

NCT ID NCT07761390

Ongoing Knowledge-focused Sponsor: Zhuliling Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study looks at whether a new scoring system, called the DIEP-MDS, can help predict the risk of blood flow problems and flap failure after DIEP flap breast reconstruction. The score is based on CT scans of the abdomen, measuring features of the blood vessels used in the surgery. Researchers will analyze data from 1,500 women, including those who had the surgery and a comparison group, to see if greater deviation from normal anatomy is linked to higher risk. The goal is to develop a tool that could help surgeons plan safer procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give surgeons a tool to better predict which patients are at higher risk of flap failure, potentially guiding surgical decisions to improve outcomes.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The scoring system may not be accurate across all patients or hospitals, and further validation is needed before it can be used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS BREAST RECONSTRUCTION POSTOPERATIVE COMPLICATIONS

Contacts and locations

Locations

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, 524001, China
Affiliated Hospital of Guizhou Medical University

Guiyang, Guizhou, 550001, China
Dongguan People's Hospital

Dongguan, Guangdong, 523000, China
Dongguan Tungwah Hospital

Dongguan, Guangdong, 523110, China
Guangzhou Concord Cancer Center

Guangzhou, Guangdong, 510700, China
Guangzhou RoyalLee Cancer Hospital

Guangzhou, Guangdong, 510700, China
Guangzhou United Family Hospital

Guangzhou, Guangdong, 510335, China
Hainan General Hospital

Haikou, Hainan, 570311, China
Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

Changsha, Hunan, 410013, China
Meizhou People's Hospital

Meizhou, Guangdong, 514031, China
Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China
Shantou Central Hospital

Shantou, Guangdong, 515031, China
Shenshan Medical Center, Sun Yat-sen Memorial Hospital of Sun Yat-sen University

Shanwei, Guangdong, 516600, China
Shenzhen Maternity and Child Healthcare Hospital

Shenzhen, Guangdong, 518000, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510120, China
The Affiliated Huizhou Hospital, Guangzhou Medical University

Huizhou, Guangdong, 516001, China
The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, 361001, China
Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, 300060, China
Yuebei People's Hospital

Shaoguan, Guangdong, 512026, China
Yunnan Cancer Hospital

Kunming, Yunnan, 650118, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.